Related Experiment Video
Updated: May 10, 2026
10:33
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
Published on: September 4, 2017
Basis and implications of the CAP88 age-specific dose coefficients
Richard Leggett1, Patricia Scofield, Keith Eckerman
1Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.
Health Physics
|June 28, 2013
Summary
Newer CAP88 software uses age-specific dose coefficients from Federal Guidance Report 13. This study explains the International Commission on Radiological Protection (ICRP) models and age-related differences in dose coefficients for environmental radionuclide exposure.
Area of Science:
- Radiological protection
- Environmental health
- Nuclear science
Background:
- CAP88 software versions now include age-specific dose coefficients.
- These coefficients are based on biokinetic and dosimetric models from Federal Guidance Report 13.
- The models largely align with International Commission on Radiological Protection (ICRP) recommendations for public dose estimation.
Purpose of the Study:
- To describe the foundation of the ICRP's age-specific biokinetic and dosimetric models.
- To analyze variations in dose coefficients across different age groups.
- To inform the application of updated models in environmental radionuclide risk assessment.
Main Methods:
- Review of ICRP reports detailing biokinetic and dosimetric models.
- Comparison of age-specific parameters within these models.
- Analysis of derived dose coefficients for various age cohorts.
Main Results:
- Detailed explanation of the ICRP's age-dependent biokinetic and dosimetric methodologies.
- Identification of specific age-related differences in dose coefficients.
- Confirmation that models are generally consistent with ICRP recommendations.
Conclusions:
- The ICRP's age-specific models provide a refined basis for dose estimation.
- Understanding age-related differences in dose coefficients is crucial for accurate risk assessment.
- Updated CAP88 versions reflect these advancements in radiological dose assessment.
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:21Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...